Monoclonal antibodies help patients fight COVID-19
Medical personnel believe the therapy can head off hospital stay and severe effects of the viral disease
October 18, 2021
BEMIDJI, Minn. -- A one-time infusion treatment is helping patients showing symptoms of COVID-19 avoid severe complications, hospitalization and the need for supplemental oxygen, according to Heather Czywczynski, a nurse practitioner at Sanford Bemidji Medical Center.
Her facility alone has given more than 700 infusions of monoclonal antibodies to COVID-positive patients who were within 10 days of the onset of symptoms since last November.
Sanford Health reported that as of Oct. 11 its entire health care system had administered more than 6,300 infusions, including more than 1,000 within the past week.